Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.33% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
NKTR · Jun 30, 2025
NEKTAR THERAPEUTICS. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000950170-25-105275General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-409.29% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
-52.42% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
100.00% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-324.21% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
267.44% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
31.19% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History12 statesHistory building
Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/7 normalizedLevel 3Jun 30, 20250/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20256/8 normalizedLevel 3Mar 31, 20265/6 normalizedLevel 3Jun 30, 20265/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 0.02%
- Current
- 0.33%
- Delta
- 0.31%
- Previous
- -468.96%
- Current
- -409.29%
- Delta
- 59.67%
- Previous
- -51.66%
- Current
- -52.42%
- Delta
- -0.76%
- Previous
- -425.76%
- Current
- -324.21%
- Delta
- 101.56%
- Previous
- 291.40%
- Current
- 267.44%
- Delta
- -23.96%
- Previous
- 37.27%
- Current
- 31.19%
- Delta
- -6.07%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · NKTR Fundamental State →Has State · NEKTAR THERAPEUTICS →Transitioned To · NKTR GROWTH_DECREASED →Transitioned To · NKTR CAPEX_INTENSITY_INCREASED →Transitioned To · NKTR CASH_GENERATION_INCREASED →Transitioned To · NKTR PROFITABILITY_INCREASED →Transitioned To · NKTR R_AND_D_INTENSITY_DECREASED →Transitioned To · NKTR SBC_INTENSITY_DECREASED →Transitioned To · NKTR Fundamental State →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.